Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration
- PMID: 12589025
- PMCID: PMC151400
- DOI: 10.1073/pnas.0438014100
Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration
Abstract
Age-related macular degeneration (AMD) is the leading cause of blindness after age 55 in the industrialized world. Severe loss of central vision frequently occurs with the exudative (wet) form of AMD, as a result of the formation of a pathological choroidal neovasculature (CNV) that damages the macular region of the retina. We tested the effect of an immunotherapy procedure, which had been shown to destroy the pathological neovasculature in solid tumors, on the formation of laser-induced CNV in a mouse model simulating exudative AMD in humans. The procedure involves administering an Icon molecule that binds with high affinity and specificity to tissue factor (TF), resulting in the activation of a potent cytolytic immune response against cells expressing TF. The Icon binds selectively to TF on the vascular endothelium of a CNV in the mouse and pig models and also on the CNV of patients with exudative AMD. Here we show that the Icon dramatically reduces the frequency of CNV formation in the mouse model. After laser treatment to induce CNV formation, the mice were injected either with an adenoviral vector encoding the Icon, resulting in synthesis of the Icon by vector-infected mouse cells, or with the Icon protein. The route of injection was i.v. or intraocular. The efficacy of the Icon in preventing formation of laser-induced CNV depends on binding selectively to the CNV. Because the Icon binds selectively to the CNV in exudative AMD as well as to laser-induced CNV, the Icon might also be efficacious for treating patients with exudative AMD.
Figures
Similar articles
-
Development of gene therapy for treatment of age-related macular degeneration.Acta Ophthalmol. 2014 Jul;92 Thesis3:1-38. doi: 10.1111/aos.12452. Acta Ophthalmol. 2014. PMID: 24953666
-
Effect of quercetin on formation of choroidal neovascularization (CNV) in age-related macular degeneration(AMD).Eye Sci. 2011 Mar;26(1):23-9. doi: 10.3969/j.issn.1000-4432.2011.01.006. Eye Sci. 2011. PMID: 21425492
-
Choroidal neovascularization in the Choroidal Neovascularization Prevention Trial. The Choroidal Neovascularization Prevention Trial Research Group.Ophthalmology. 1998 Aug;105(8):1364-72. doi: 10.1016/s0161-6420(98)98014-9. Ophthalmology. 1998. PMID: 9709744 Clinical Trial.
-
[Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].Nippon Ganka Gakkai Zasshi. 2007 Mar;111(3):232-68; discussion 269. Nippon Ganka Gakkai Zasshi. 2007. PMID: 17402564 Review. Japanese.
-
Age-related macular degeneration: epidemiology and optimal treatment.Drugs Aging. 2002;19(2):101-33. doi: 10.2165/00002512-200219020-00003. Drugs Aging. 2002. PMID: 11950377 Review.
Cited by
-
Novel therapies for proliferative retinopathies.Ther Adv Chronic Dis. 2022 Dec 2;13:20406223221140395. doi: 10.1177/20406223221140395. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 36479142 Free PMC article. Review.
-
Tissue factor with age-related macular degeneration.Int J Ophthalmol. 2012;5(5):609-13. doi: 10.3980/j.issn.2222-3959.2012.05.13. Epub 2012 Oct 18. Int J Ophthalmol. 2012. PMID: 23166874 Free PMC article.
-
The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosis.Am J Pathol. 2010 Feb;176(2):1050-6. doi: 10.2353/ajpath.2010.090757. Epub 2009 Dec 30. Am J Pathol. 2010. PMID: 20042667 Free PMC article.
-
Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer.BMC Immunol. 2010 Oct 12;11:49. doi: 10.1186/1471-2172-11-49. BMC Immunol. 2010. PMID: 20939894 Free PMC article.
-
IKK2 inhibition attenuates laser-induced choroidal neovascularization.PLoS One. 2014 Jan 28;9(1):e87530. doi: 10.1371/journal.pone.0087530. eCollection 2014. PLoS One. 2014. PMID: 24489934 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous